arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Fortrea Holdings Inc.

FTRE
$18.45 ▲ +0.77 (+4.33%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
20 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
15
Health
Poor
Bearish
auto_awesome

Analytical Summary

Fortrea Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield
Revenue Growth -4.5%
Op. Margin 2.2%
ROIC 10.4%
FCF / Share $0.30
Trailing P/E
Price / Book 3.4x
FCF Yield 1.7%
Debt / Equity 1.98
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$678.20M
↓ -4.5%
Net Income Profit after all expenses
$-23.60M
↑ +95.8%
Operating Margin Operating profit as % of sales
2.2%
↑ +508.5% 7th
FCF / Share Free cash flow per share
$0.30
↑ +267.8%
Long-Term Debt Long-term obligations
$1.04B
↓ -0.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
18
Returns
4
Financial Health
22
Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 20 quarters